|
CREB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.180700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.155700E-02 |
| Normal-vs-Stage2 |
2.001600E-01 |
| Normal-vs-Stage3 |
4.807300E-04 |
| Normal-vs-Stage4 |
5.59169999999609E-05 |
| Stage1-vs-Stage2 |
7.708400E-01 |
| Stage1-vs-Stage3 |
1.629820E-02 |
| Stage1-vs-Stage4 |
3.180700E-03 |
| Stage2-vs-Stage3 |
2.021600E-01 |
| Stage2-vs-Stage4 |
9.064000E-02 |
| Stage3-vs-Stage4 |
4.668800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.364300E-03 |
| Normal-vs-AfricanAmerican |
1.842220E-04 |
| Normal-vs-Asian |
3.667400E-01 |
| Caucasian-vs-AfricanAmerican |
3.572400E-02 |
| Caucasian-vs-Asian |
3.574200E-02 |
| AfricanAmerican-vs-Asian |
8.238300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.618080E-03 |
| Normal-vs-Female |
2.086100E-02 |
| Male-vs-Female |
4.124600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.835900E-02 |
| Normal-vs-Age(41-60Yrs) |
5.211500E-02 |
| Normal-vs-Age(61-80Yrs) |
9.034200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.182600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.812200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.505600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.542400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.184610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.273900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.020000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.504000E-01 |
| Normal-vs-Grade 2 |
1.830240E-01 |
| Normal-vs-Grade 3 |
9.577300E-04 |
| Normal-vs-Grade 4 |
3.73490000000753E-05 |
| Grade 1-vs-Grade 2 |
3.833800E-01 |
| Grade 1-vs-Grade 3 |
4.550000E-02 |
| Grade 1-vs-Grade 4 |
9.283700E-03 |
| Grade 2-vs-Grade 3 |
8.715800E-03 |
| Grade 2-vs-Grade 4 |
1.298430E-03 |
| Grade 3-vs-Grade 4 |
1.166040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.595800E-01 |
| Normal-vs-ccB subtype |
9.449600E-04 |
| ccA subtype-vs-ccB subtype |
8.580100E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.132350E-02 |
| Normal-vs-N1 |
2.740200E-01 |
| N0-vs-N1 |
7.302200E-01 |
|
|
